Handcrafted vs. Deep Radiomics vs. Fusion vs. Deep Learning: A Comprehensive Review of Machine Learning -Based Cancer Outcome Prediction in PET and SPECT Imaging
By: Mohammad R. Salmanpour , Somayeh Sadat Mehrnia , Sajad Jabarzadeh Ghandilu and more
Potential Business Impact:
Helps doctors predict cancer using scans better.
Machine learning (ML), including deep learning (DL) and radiomics-based methods, is increasingly used for cancer outcome prediction with PET and SPECT imaging. However, the comparative performance of handcrafted radiomics features (HRF), deep radiomics features (DRF), DL models, and hybrid fusion approaches remains inconsistent across clinical applications. This systematic review analyzed 226 studies published from 2020 to 2025 that applied ML to PET or SPECT imaging for outcome prediction. Each study was evaluated using a 59-item framework covering dataset construction, feature extraction, validation methods, interpretability, and risk of bias. We extracted key details including model type, cancer site, imaging modality, and performance metrics such as accuracy and area under the curve (AUC). PET-based studies (95%) generally outperformed those using SPECT, likely due to higher spatial resolution and sensitivity. DRF models achieved the highest mean accuracy (0.862), while fusion models yielded the highest AUC (0.861). ANOVA confirmed significant differences in performance (accuracy: p=0.0006, AUC: p=0.0027). Common limitations included inadequate handling of class imbalance (59%), missing data (29%), and low population diversity (19%). Only 48% of studies adhered to IBSI standards. These findings highlight the need for standardized pipelines, improved data quality, and explainable AI to support clinical integration.
Similar Papers
Comparative Evaluation of Radiomics and Deep Learning Models for Disease Detection in Chest Radiography
Image and Video Processing
Helps doctors find lung sickness using AI.
The added value for MRI radiomics and deep-learning for glioblastoma prognostication compared to clinical and molecular information
Machine Learning (CS)
Helps doctors guess how long brain cancer patients live.
Hybrid Deep Learning and Handcrafted Feature Fusion for Mammographic Breast Cancer Classification
Image and Video Processing
Helps doctors find breast cancer faster.